Authors:
SITBON G
ALBERT J
APERIA K
HURTIG M
JOHANSSON C
MOBERG C
HOLMBERG V
SANDSTROM E
Citation: G. Sitbon et al., PATTERN OF DRUG-RESISTANCE MUTATIONS DURING COMBINATION THERAPY WITH AZT AND ZALCITABINE DIDANOSINE, Journal of acquired immune deficiency syndromes and human retrovirology, 10, 1995, pp. 30-30
Authors:
KARLSSON A
PARSMYR K
APERIA K
SANDSTROM E
FENYO EM
ALBERT J
Citation: A. Karlsson et al., BIOLOGICAL PHENOTYPE OF HIV-1 ISOLATES AS A MARKER FOR RESPONSE TO TREATMENT AND DEVELOPMENT OF DRUG-RESISTANCE, Journal of acquired immune deficiency syndromes and human retrovirology, 10, 1995, pp. 35-35
Authors:
COX SW
APERIA K
SANDSTROM E
HOLMBERG V
MORFELDTMANSON L
BROSTROM C
WAHREN B
ALBERT J
Citation: Sw. Cox et al., CROSS-RESISTANCE BETWEEN AZT, DDL AND OTHER ANTIRETROVIRAL DRUGS IN PRIMARY ISOLATES OF HIV-1, Antiviral chemistry & chemotherapy, 5(1), 1994, pp. 7-12
Citation: Sw. Cox et al., COMPARISON OF THE SENSITIVITIES OF PRIMARY ISOLATES OF HIV TYPE-2 ANDHIV TYPE-1 TO ANTIVIRAL DRUGS AND DRUG-COMBINATIONS, AIDS research and human retroviruses, 10(12), 1994, pp. 1725-1729
Authors:
KARLSSON A
PARSMYR K
APERIA K
SANDSTROM E
FENYO EM
ALBERT J
Citation: A. Karlsson et al., MT-2 CELL TROPISM OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES AS A MARKER FOR RESPONSE TO TREATMENT AND DEVELOPMENT OF DRUG-RESISTANCE, The Journal of infectious diseases, 170(6), 1994, pp. 1367-1375
Citation: Sw. Cox et al., SYNERGISTIC INHIBITION OF PRIMARY ISOLATES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 BY COMBINATIONS OF 3'-FLUORO-3'-DEOXYTHYMIDINE AND 2',3'-DIDEOXYINOSINE, Antiviral chemistry & chemotherapy, 4(4), 1993, pp. 241-244